Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is one of the best performing pharma stocks in 2025. Amylyx Pharmaceuticals, Inc.

DESIGNED in the late 60s by Richard Teague, the father of the Jeep Cherokee XJ and Pacer – take a look at the award-winning ...

The 1968 AMC AMX arrived as a compact two-seater in a muscle car era obsessed with size, yet it quickly proved that a shorter ...

BofA Securities noted that improved cash generation in the industry has resulted in increased dividends for investors, a ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Amylyx (AMLX) announced the selection of AMX0318, a long-acting glucagon-like peptide-1 receptor antagonist, as a development candidate for post-bariatric hypoglycemia, or PBH, and other rare diseases ...

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) ("Amylyx" or the "Company") today announced the selection of AMX0318, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist, as a development ...

History has shown that wars are capable of evolving faster than aircraft design cycles. Platforms optimized for nuclear ...

Actualize, the UAE-headquartered AI company with a London presence, founded by ex-Googlers Muhammed Shabreen and Khalid Ghiboub, has onboarded serial entrepreneur and Managing Director of AMX Ventures ...

Amylyx Pharmaceuticals Inc. has nominated AMX-0318, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist, as a development candidate for post-bariatric hypoglycemia and other rare ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Detailed price information for America Movil S.A.B. DE C.V. ADR (AMX-N) from The Globe and Mail including charting and trades.